Evoke Pharma Inc. Stock
Evoke Pharma Inc. Stock
Evoke Pharma Inc. took a tumble today and lost -€0.088 (-17.600%).
So far the community has only identified positive things for Evoke Pharma Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Evoke Pharma Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Evoke Pharma Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Evoke Pharma Inc. | -17.600% | 0.980% | -4.186% | -75.476% | -56.402% | -96.497% | -93.535% |
| Cellectar BioSciences Inc. | 1.950% | 7.692% | 1.987% | 140.625% | 35.088% | -71.481% | - |
| Beximco Pharmaceuticals Ltd. GDR | - | 0.000% | 3.810% | 9.548% | -0.909% | -52.865% | -22.143% |
| Arca Biopharma | -15.760% | -4.321% | 3.333% | 58.974% | 99.357% | 14.815% | -94.533% |
Comments
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for EVOK provided by MarketBeat
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for EVOK provided by MarketBeat
Evoke Pharma, Inc. (NASDAQ: EVOK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for EVOK provided by MarketBeat